|
|||||
|
|
Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes |
|
| Authors: | Anna R. Kahkoska,Trine Julie Abrahamsen,G. Caleb Alexander,Tellen D. Bennett,Christopher G. Chute,Melissa A. Haendel,Klara R. Klein,Hemalkumar Mehta,Joshua D. Miller,Richard A. Moffitt,Til Stü rmer,Kajsa Kvist,John B. Buse,N3C Consortium |
| Abstract: | |
| Keywords: | |